These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22222782)

  • 1. Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases.
    Larsen MK; Berge KE; Leren TP; Nissen PH; Hansen J; Kristensen IB; Banner J; Jensen HK
    Int J Legal Med; 2013 Jan; 127(1):139-44. PubMed ID: 22222782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases.
    Tester DJ; Spoon DB; Valdivia HH; Makielski JC; Ackerman MJ
    Mayo Clin Proc; 2004 Nov; 79(11):1380-4. PubMed ID: 15544015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmortem genetic screening of SNPs in RyR2 gene in sudden unexplained nocturnal death syndrome in the southern Chinese Han population.
    Huang L; Liu C; Tang S; Su T; Cheng J
    Forensic Sci Int; 2014 Feb; 235():14-8. PubMed ID: 24447446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmortem molecular analysis for fatal arrhythmogenic disease in sudden unexplained death.
    Nishio H; Suzuki K
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S119-20. PubMed ID: 19261510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel mutation V2321M of the cardiac ryanodine receptor gene of sudden unexplained death and a phenotypic study of the gene mutations.
    Nishio H; Iwata M; Tamura A; Miyazaki T; Tsuboi K; Suzuki K
    Leg Med (Tokyo); 2008 Jul; 10(4):196-200. PubMed ID: 18262818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
    Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.
    Marjamaa A; Laitinen-Forsblom P; Lahtinen AM; Viitasalo M; Toivonen L; Kontula K; Swan H
    BMC Med Genet; 2009 Feb; 10():12. PubMed ID: 19216760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan.
    Kawamura M; Ohno S; Naiki N; Nagaoka I; Dochi K; Wang Q; Hasegawa K; Kimura H; Miyamoto A; Mizusawa Y; Itoh H; Makiyama T; Sumitomo N; Ushinohama H; Oyama K; Murakoshi N; Aonuma K; Horigome H; Honda T; Yoshinaga M; Ito M; Horie M
    Circ J; 2013; 77(7):1705-13. PubMed ID: 23595086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.
    Ohno S; Omura M; Kawamura M; Kimura H; Itoh H; Makiyama T; Ushinohama H; Makita N; Horie M
    Europace; 2014 Nov; 16(11):1646-54. PubMed ID: 24394973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency Syndrome.
    Roston TM; Wei J; Guo W; Li Y; Zhong X; Wang R; Estillore JP; Peltenburg PJ; Noguer FRI; Till J; Eckhardt LL; Orland KM; Hamilton R; LaPage MJ; Krahn AD; Tadros R; Vinocur JM; Kallas D; Franciosi S; Roberts JD; Wilde AAM; Jensen HK; Sanatani S; Chen SRW
    JAMA Cardiol; 2022 Jan; 7(1):84-92. PubMed ID: 34730774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.
    Tester DJ; Kopplin LJ; Will ML; Ackerman MJ
    Heart Rhythm; 2005 Oct; 2(10):1099-105. PubMed ID: 16188589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
    Medeiros-Domingo A; Bhuiyan ZA; Tester DJ; Hofman N; Bikker H; van Tintelen JP; Mannens MM; Wilde AA; Ackerman MJ
    J Am Coll Cardiol; 2009 Nov; 54(22):2065-74. PubMed ID: 19926015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors.
    Tester DJ; Dura M; Carturan E; Reiken S; Wronska A; Marks AR; Ackerman MJ
    Heart Rhythm; 2007 Jun; 4(6):733-9. PubMed ID: 17556193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
    Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.
    Miyata K; Ohno S; Itoh H; Horie M
    Intern Med; 2018 Jul; 57(13):1813-1817. PubMed ID: 29434162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals.
    Landstrom AP; Dailey-Schwartz AL; Rosenfeld JA; Yang Y; McLean MJ; Miyake CY; Valdes SO; Fan Y; Allen HD; Penny DJ; Kim JJ
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28404607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
    Roston TM; Guo W; Krahn AD; Wang R; Van Petegem F; Sanatani S; Chen SR; Lehman A
    J Electrocardiol; 2017; 50(2):227-233. PubMed ID: 27646203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance.
    Giudicessi JR; Lieve KVV; Rohatgi RK; Koca F; Tester DJ; van der Werf C; Martijn Bos J; Wilde AAM; Ackerman MJ
    Circ Genom Precis Med; 2019 May; 12(5):e002510. PubMed ID: 31112425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry.
    Roston TM; Haji-Ghassemi O; LaPage MJ; Batra AS; Bar-Cohen Y; Anderson C; Lau YR; Maginot K; Gebauer RA; Etheridge SP; Potts JE; Van Petegem F; Sanatani S
    PLoS One; 2018; 13(11):e0205925. PubMed ID: 30403697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships.
    Olubando D; Hopton C; Eden J; Caswell R; Lowri Thomas N; Roberts SA; Morris-Rosendahl D; Venetucci L; Newman WG
    J Hum Genet; 2020 Jun; 65(6):531-539. PubMed ID: 32152366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.